Madden et al. also found several ECM architecture regulating genes among the gene products identified as glioma endothelial markers, including heparan sulfate proteoglycan 2, several type IV collagen transcript variants, and matrix metallopeptidase 14 (MMP14) [50]. The gene discussed is HSPG2; the disease is central nervous system cancer.